GLP-1 medications have revolutionized medical weight loss, offering significant, sustainable results for individuals struggling to lose weight through diet and exercise alone. If you’re exploring weight loss clinics in Pembroke Pines, you’ve likely heard of the two leading options: Semaglutide and Tirzepatide.
But what is the difference, and which one is right for you?
Understanding Semaglutide
Semaglutide (the active ingredient in Wegovy® and Ozempic®) is a GLP-1 receptor agonist. It works by mimicking a hormone that targets areas of the brain that regulate appetite and food intake. It helps you feel full sooner, reduces cravings, and slows gastric emptying.
Average Weight Loss: Clinical trials show an average weight loss of about 15% of body weight over 68 weeks.
Understanding Tirzepatide
Tirzepatide (the active ingredient in Zepbound® and Mounjaro®) is a dual-action medication. It acts on both GLP-1 and GIP receptors. This dual action not only suppresses appetite but also significantly improves how the body breaks down sugar and fat.
Average Weight Loss: Clinical trials show an average weight loss of up to 20-22% of body weight over 72 weeks, making it slightly more potent than Semaglutide for many patients.
Which Should You Choose?
The choice between Semaglutide and Tirzepatide depends on several factors, including your specific weight loss goals, medical history, tolerance to side effects (which can include mild nausea or digestive changes), and budget.
At Be Env Wellness & Aesthetics, our medical weight loss program is not a one-size-fits-all approach. Nurse Practitioner Novia Markes conducts a comprehensive metabolic assessment to determine the most effective and safe medication protocol for your unique biology.
We combine these powerful medications with holistic lifestyle support, nutritional guidance, and ongoing monitoring to ensure you not only lose the weight but keep it off.
Ready to start your transformation? Explore our medical weight loss program in Pembroke Pines.